(1 - 14 from 18
)
Atox Bio to seek funds by year-end for more trials - Reuters
www.reuters.com
Israeli biotechnology firm Atox Bio, developing a drug it hopes can treat severe infections such as those caused by flesh-eating bacteria and deadly viruses,...
Atox Bio to Seek Funds by Year-End for More Trials | CHEManager
www.chemanager-online.com
Atox Bio to Seek Funds by Year-End for More Trials. Israeli biotechnology firm Atox Bio, developing a drug it hopes can treat severe infections such as those...
Israeli clinical stage Atox Bio Closes $30 Million Investment
jewishbusinessnews.com
... significant achievements we have made to date in the development of Reltecimod,” said Dan Teleman, Chief Executive Officer of Atox Bio.
sorted by relevance / date